TY - GEN AU - Atalay,Selma AU - van den Reek,Juul M P A AU - den Broeder,Alfons A AU - van Vugt,Lieke J AU - Otero,Marisol E AU - Njoo,Marcellus D AU - Mommers,Johannes M AU - Ossenkoppele,Paul M AU - Koetsier,Marjolein I AU - Berends,Maartje A AU - van de Kerkhof,Peter C M AU - Groenewoud,Hans M M AU - Kievit,Wietske AU - de Jong,Elke M G J TI - Comparison of Tightly Controlled Dose Reduction of Biologics With Usual Care for Patients With Psoriasis: A Randomized Clinical Trial SN - 2168-6084 PY - 2020///1229 KW - Adalimumab KW - administration & dosage KW - Adult KW - Aged KW - Biological Products KW - Dermatologic Agents KW - Drug Tapering KW - Etanercept KW - Female KW - Humans KW - Male KW - Middle Aged KW - Netherlands KW - Prospective Studies KW - Psoriasis KW - drug therapy KW - Quality of Life KW - Severity of Illness Index KW - Treatment Outcome KW - Ustekinumab N1 - Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't UR - https://doi.org/10.1001/jamadermatol.2019.4897 ER -